Kenya might experience a drop in vaccine supply after the Covax facility, the main source of Covid-19 doses for low income countries, slashed delivery by 25 percent.
Kenya is racing towards vaccinating 10 million people by year’s end and like other African countries, depends on Covax for vaccines whose supply is now facing challenges including in manufacturing, capacity, export restrictions, regulatory approvals, funding, and readiness of countries in their national jab campaigns.